Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001622627-25-000011
Filing Date
2025-02-13
Accepted
2025-02-13 12:50:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8955
2 ex_a_sprb_13ga.htm EX-99.A BD-DIR-RESOL 2434
  Complete submission text file 0001622627-25-000011.txt   13100
Mailing Address 15 WELLESLEY STREET WEST SUITE 326 TORONTO A6 M4Y 0G7
Business Address 25 ADMIRAL ROAD TORONTO A6 M5R 2L4 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: SCHEDULE 13G/A

Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Subject) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91764 | Film No.: 25618754
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)